Suzanne Rivera named new VP for research

Provost W.A. "Bud" Baeslack III announced, on November 4th, the appointment of Suzanne M. Rivera as Case Western Reserve´s new vice president for research, effective this month. Rivera, the university´s associate vice president for research since January 2011, emerged as the top choice after an extensive process involving campuswide nominations of internal university candidates. Since coming to CWRU, Rivera has distinguished herself through a commitment to collaboration and a focus on systems and processes.
Read more about her.


Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
December 9, 2014  

Limited Submission Reminder: NSF Materials Innovation Platforms (MIP)

Key Deadlines: January 5, 2015, 5:00pm (CWRU Internal Submission Deadline), March 2, 2015, 5:00pm EST.

The Division of Materials Research (DMR) seeks to significantly accelerate advances in materials research and engineering through the rapid discovery of new materials and phenomena by developing a new midscale user facility program - Materials Innovation Platforms (MIP) program. MIPs embrace the paradigm set forth by the Materials Genome Initiative (MGI) which strives to "discover, manufacture, and deploy advanced materials in half the time and at a fraction of the cost." Platforms respond to the increasing complexity of conducting materials research that requires the close collaboration of multidisciplinary teams who have access to cutting edge tools. To accelerate research outcomes, Platforms conduct research through iterative "closed-loop" efforts among the areas of materials synthesis, characterization, theory, and the application of theory through modeling and/or simulation. The in-house research conducted by a MIP is transformational and focuses on a targeted materials grand challenge and/or a technological outcome (e.g., understanding complexity, discovery of new phenomena and materials, etc.) that addresses a national priority.

MIPs push the frontiers in materials research by advancing the capabilities of current state-of-the-art experimental tools through the development of new techniques and the next generation of instrumentation that will lead to understanding and discovering new phenomena as well as the discovery of complex functional material systems. In addition, it is expected that open access to these cutting edge tools will strengthen collaborations among scientists and enable researchers to work in new ways, while fostering new modalities of multidisciplinary education and training. The user facility aspect of a Platform accounts for approximately 50% of the collaborative effort, where a MIP provides access to unique high-quality, state-of-the-art instrumentation and technological services through a staff of experts that are accessible to external researchers and all types of institutions. Due to this convergence of expertise, MIPs will serve as focal points that promote cross-fertilization of ideas between internal and external researchers.

The Platform, the tools and techniques developed, and the resulting new materials are themselves meant to be transformative. The US, once a global leader in materials synthesis, has fallen behind in the science of crystal growth. To rebuild technical strength in this area, the initial MIPs will focus on developing new bulk and thin film crystalline hard materials. The scientific focus of the MIP program is subject to change from competition to competition. MIPs are anticipated to be five year awards totaling $10,000,000 to $25,000,000 for the award period. MIP awards are eligible for a one-time five-year renewal, subsequent to a rigorous and favorable review by NSF. To cover the breadth of this endeavor, it is expected that proposed projects will be directed by a team of at least three Senior Personnel with complementary expertise. Equipment acquisition is expected in the first few years, but yearly budget should not exceed $7.0M.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 

Department of Defense

The Fiscal Year 2014 (FY14) Defense Appropriations Act provides research funding for the peer reviewed programs managed by the Department of Defense (DOD) office of Congressionally Directed Medical Research Programs (CDMRP).

Gulf War Illness Research Program (GWIRP)
Innovative Treatment Evaluation Award 2

Breast Cancer Research Program (BCRP)
Breakthrough Award Funding Levels 1 and 2
Breakthrough Award Funding Levels 3 and 4

 
Ohio Third Frontier (OTF), Ohio Development Services Agency

The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:

Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.

Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.

The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.

Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or mhaag@case.edu.

For more information on the TVSF visit the Ohio Third Frontier website.

 
Patient-Centered Outcomes Research Institute (PCORI)

Pipeline to Proposal Awards Tier I - Pre-Engagement/Community Projects fund the building of the community and capacity necessary to later develop a patient-centered comparative effectiveness research (CER) project addressing the issue of interest to the awardee

The Tier I awards are for individuals or groups who are not usual candidates for research funding. This program is intended to support those individuals and groups with critically important ideas who may not have other opportunities for research funding. In order to qualify for Tier I funding, you must demonstrate success in a past community-building project. The project doesn’t have to have been health-related. You need to explain how you engaged the community and formed partnerships to achieve your goal and how, by building relationships and forming partnerships, you were able to overcome any obstacles.

Letter of Intent (LOI) deadline: December 23, 2014

Application Deadline: February 16, 2015

Funds available up to: $15,000

For more information, visit the PCORI website.

 
The Cleveland Area Reliant IRB Review Process

The Cleveland Area Reliant Institutional Review Board (IRB) Review process includes participation by the Case Western Reserve University (CWRU) Social, Behavioral, and Educational Research (SBER) IRB, the Cleveland Clinic (CC) IRB, MetroHealth Medical Center (MHMC) IRB, and University Hospitals Case Medical Center (UHCMC) IRB. The process relies on executed IRB Authorization Agreements (IAA) between the institutions. These agreements document that all applicable human research subjects protection considerations will be made by one Institutional Review Board (IRB), which will be deemed the IRB of record. The IRBs of the other Cleveland area institutions will accept the approval of the IRB of record through the Reliant Review process. The goal is to eliminate duplication of effort and multiple applications for submission of the same protocol, and to encourage scientific collaboration among the affiliated institutions.

What types of studies are eligible for the Reliant Review Process?
Any type of human research study could be eligible for the Reliant Review process. These include but are not limited to investigator-initiated, federally-funded, foundation-supported, industry-sponsored, and non-funded studies.

The fundamental requirement is that a collaborating investigator must be named at each site where the research will occur. It is important for the Principal Investigator at the lead study site to work with the IRB of record throughout the Reliant Review Process to initiate acceptance of IRB approval at each collaborating site.

For further information, contact Kim Volarcik at (216) 368-0134 or kav6@case.edu.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.